HealthInsights

The Physiology of ER-Associated Degradation (ERAD): The ER's Disposal System

By Sam Parker
Cell BiologyERADEndoplasmic ReticulumProteostasis

The Physiology of ER-Associated Degradation (ERAD): The ER's Disposal System

The endoplasmic reticulum (ER) is the cell's main factory for the folding and assembly of secretory and membrane proteins. However, this process is error-prone. To prevent the accumulation of defective proteins, which can be toxic, the ER employs a stringent quality control system known as ER-associated degradation (ERAD).

The Four Stages of ERAD

ERAD is a multistep process that identifies, transports, and destroys misfolded proteins.

  1. Recognition: The first challenge is distinguishing misfolded proteins from folding intermediates. Specialized ER chaperones (like BiP) and lectins (like OS-9) recognize exposed hydrophobic patches or specific glycan signals that indicate a protein is terminally misfolded.
  2. Retrotranslocation (Dislocation): Once identified, the target protein must be moved from the ER lumen or membrane back into the cytosol. This is achieved through a proteinaceous channel, or "retrotranslocon," often involving the Sec61 complex or Hrd1.
  3. Ubiquitination: As the protein emerges into the cytosol, it is tagged with ubiquitin chains by E3 ubiquitin ligases (such as Hrd1 or gp78) that are anchored in the ER membrane. This tagging marks the protein for destruction.
  4. Degradation: The polyubiquitinated protein is pulled completely into the cytosol by the p97 (VCP) ATPase and then delivered to the 26S proteasome, where it is broken down into small peptides.

ERAD and the Unfolded Protein Response (UPR)

When the capacity of the ERAD system is overwhelmed by a high volume of misfolded proteins (a condition known as ER stress), the cell activates the Unfolded Protein Response (UPR). The UPR upregulates the expression of ERAD components to increase the "disposal" capacity of the ER, while simultaneously slowing down general protein synthesis to reduce the burden on the ER.

Clinical Relevance

ERAD is involved in the pathogenesis of several diseases. In Cystic Fibrosis, the most common mutation (ΔF508) causes the CFTR protein to misfold slightly. Although the protein might still be functional, the ERAD system recognizes it as defective and destroys it before it can reach the cell surface.

Conversely, some viruses hijack the ERAD pathway to destroy immune system proteins, such as MHC class I molecules, allowing the virus to evade detection.

Conclusion

The ERAD pathway is a critical component of cellular proteostasis. By ensuring that only correctly folded proteins exit the ER, ERAD maintains the integrity of the secretome and protects the cell from the consequences of protein misfolding.